Saturday, December 27, 2008

Best time to start a business

I've recently seen a number of articles that this is the best time to invest in early stage companies. The theory is that the ones that can get going and survive in this economy are going to be the strongest. This is an interesting article on the topic. The big issue is whether there is sufficient capital to support these kinds of endeavors.
Issue Date:  December 15, 2008, Posted On: 12/23/2008

At MIT VC powwow there is no time like the present

Experts: Despite slowdown startup jump is good move



By MARK CONNORS

CAMBRIDGE, Mass. â€" Is starting a new business in the middle of what may prove to be the most severe economic downturn since the Great Depression a good idea? Surprisingly, experts at a recent MIT conference in Cambridge said the timing may be perfect.

The nation lost 533,000 jobs in November, the 11th consecutive month the U.S. economy has shed jobs, according to Department of Labor statistics. The unemployment rate currently stands at 6.7 percent â€" a 15-year high â€" and the Dow Jones Industrial Average index has lost about 40 percent of its value in the past year. And many economic forecasters say the worst is yet to come. 

Nevertheless, the consensus among experts at the Sloan Venture Capital Conference, held on Dec. 6 at the Charles Hotel in Cambridge, is that the timing couldn’t be better to start a new business.

“You’ve got a great deal of people from tech companies who have been laid off, so you’ve got a great pool of talent out there, and costs for things like office space and supplies and even salaries are down. So from an entrepreneur’s standpoint, it’s a great time to start a business,� said David Fialkow, a speaker at the event and managing director of General Catalyst Partners in Cambridge.

The conference, hosted by the Massachusetts Institute of Technology and now running in its 11th year, featured more than 40 speakers, including a slew of venture capitalists, regulatory officials, MBA students, industry veterans and startup entrepreneurs. Gitika Srivastava, a former technology entrepreneur who now advises Boston-area startups, co-chaired the conference. Indians are active in the Boston area’s venture capital scene and were well represented at this year’s event. Of the conference’s 32 organizers, 10 were of Indian origin.

Jamshed Irani, director of Tata Sons, a massive India-based business conglomerate that owns over 96 companies spread across six continents, delivered the conference’s luncheon keynote address. 

Irani, who was recently honored with a Lifetime Achievement Award by the Indian government, spoke about the healthy state of startup capital in India.

“It used to be that you had to be in Cambridge or the Silicon Valley [to get venture capital funding], but I’m happy to say that is changing,� Irani said. “India is very much fair game.�

Several United States-based venture capital firms have launched India-specific funds, including industry giants Matrix Partners, Sequoia and Canaan Partners.

MIT alumnus Eran Egozy, co-founder and chief technical officer of Harmonix Inc., the Cambridge-based company behind the wildly popular video games “Guitar Hero� and “Rock Band,� delivered the conference’s closing remarks. TIME Magazine recently named him one of its 100 Most Influential People in the World.

But Egozy, a bespectacled, skinny figure who sports a thick head of curly black hair and dresses formally, does not exhibit a typical rock star appearance. He acknowledges his musical history consists almost entirely of playing the clarinet.

“People ask me all the time if we are going to come out with ‘Clarinet Hero,’� Egozy said. “They think it’s hilarious. Well, the answer is there will never be [a ‘Clarinet Hero’] because I don’t think anyone would buy it.�

Egozy told the story behind Harmonix and the company’s 12-year road to commercial success, one that Egozy termed “a wild ride.� At one point, the company was about to go out of business before a well-timed round of venture capital kept the business alive.

“People think of ‘Guitar Hero’ as this overnight success story,� Egozy said. “Nothing could be further from the truth.�

Harmonix was launched in the media lab at MIT when Egozy and his partners toiled away at building music improvisation technology â€" a primitive precursor to the company’s Guitar Hero game.

“When we saw the joy that [the technology] brought to people, when we saw the twinkle in their eyes when they played it, we knew we were on to something,� Egozy said.

But the early going was a tough road for Harmonix. Egozy and his partners decided to try to market their innovations as a music improvisation licensing technology. Egozy asked the audience for a show of hands of those interested in such licensing rights. Only two people raised their hands. “Well, in 1995, it was more like zero people,� Egozy said to laughter. The business saw no revenues in its four years.

Undaunted by their initial stumbles, Egozy and his partners decided to try to harness the technology in the form of video games in 1999, eventually leading to the release of “Guitar Heroâ€� in 2005 and “Rock Bandâ€� in 2007. Egozy’s story was a welcome one for the hordes of startup entrepreneurs at the conference, with many looking to find the same commercial spark Harmonix found. 

Thirty startup companies, selected from a pool of more than 100 applicants, showcased their business plans at the conference’s “Entrepreneur Showcase,� where they competed for the attention of dozens of venture capitalists who attended the event.

The startups represented a broad and sometimes eclectic range of industries and platforms. Participating businesses included: Free Flow Power, a company that harnesses energy from the natural flow of water; YouCastr, an online sports network for fans of ‘non-mainstream sports’; Promethean Power, developers of a solar-powered cold-storage system for the preservation of perishable foods; and AugmentRx, a pharmaceutical startup behind a new “tissue bulking agent� for the treatment of urinary incontinence.

“For companies like us, this is the place to be,� said Bharat Nair, a representative of an online security startup.

Friday, December 19, 2008

Innovation in Executive Development

I'm on a quest to find what is new and innovative in Executive Development. I have to admit it is not an easy search. So with that in mind I was quite pleased to see this report done by Ashridge on Innovations in Executive Development:

http://www.ashridge.org.uk/website/IC.nsf/wFARATT/Innovation%20in%20Executive%20Development:%20A%20case-based%20study%20of%20practice%20in%20international%20business%20schools/$file/InnovationInExecutiveDevelopment.pdf

It's long but if you are interested start backwards and review the cases. Each one is interesting in its own right but I wondering what is really new. There are new twists like using social networking software design to create learning groups but I don't see the innovation.

There is a lot of referencing of Experiential Learning and John Dewey and David Kolb. There is a clear view that building dissonance and challenge into programmes is important. Certainly, there is an overriding view that what happens between participants is just as important as what knowledge is transmitted by instructors.


There is also a lot of incorporating readily available package training into "custom programmes". These are run under the auspices of Higher Education. Maybe, HE is only discovering how adults actually learn ... Scary since this sector now dominates educating executives!

Comments? Also any innovations you would highlight?

Thursday, December 4, 2008

New business model for financing pharmaceutical development

This is an interesting development to track. Will this business model really bring returns? Is this a bigger opportunity for university or independent researchers?
GOLDMAN UNVEILS PLANS FOR PHARMA RESEARCH FUNDING
By Andrew JackPublished: December 3 2008 02:00 | Last updated: December 3 2008 02:00
Goldman Sachs is in talks to provide hundreds of millions of dollars of funding to a large pharmaceutical company, in the first evidence of a new business model for the sector that will see financing shifted away from funding companies and towards targeted co-development of specific medicines.
Jon Symonds, managing director at the investment bank in London and former finance director of AstraZeneca, the Anglo-Swedish pharmaceutical group, said a first deal to create a new hybrid model of research and development should be finalised early next year.
This article can be found at:
http://www.ft.com/cms/s/0/e92f9d3c-c0db-11dd-b0a8-000077b07658,_i_email=y.html
"FT" and "Financial Times" are trademarks of The Financial Times.
Copyright The Financial Times Ltd 2008

Leading in Challenging Times ....

A big dilemma in challenging times is where to put the locus of control: in the centre or at the unit level? In "normal" times this is also a choice but in economically challenging times the strategic considerations are different. Putting the locus of control at the centre may force more aggressive cost cutting. In some circumstances short-term fiat is the most desirable lever for change available to senior executives. Leadership from the centre with close involvement of units on key areas for improvement may lead to more sustainable efficiencies. On the other hand, in recessions different markets enter and emerge from the recession at different speeds. So if units or geographies are dispersed then central management of costs may overshoot control one way or the other. Perhaps, an alternative organisational strategy needs to be put in place. This would be to devolve as much of the P/L to the smallest possible unit and cut coordination (aka headquarter) costs. This model was once quite popular ... It has a critical downside in that after a while it is hard to obtain significant revenue growth unless the unit is in a truly spectacular market or is fantastically innovative. In better times, revenue growth comes at the edges between units. In hard times, just focusing accountability for P/L to smaller units make cost adjustments possible in turbulent markets.

Monday, December 1, 2008

Leading in Challenging Times

Current times remind me of a metaphor I have not used for about 15 years. Leading is like captaining a ship or if you lead multiple units a fleet of ships. In challenging times like today we need to see our ships as manoeuvring through narrow and quite dangerous straits. Our attention has to be on looking only a small distance ahead and getting through, avoiding among other things perilous rocks. Certainly, we can dream about where we are eventually going but our focus is very definitely short-term. When the ship or your fleet starts to emerge into wider waters you can once again plot a course, set direction that is expansive and take advantage of the environment you are in. You know that the open seas are not peril free but you have a wider range of options.

If you are leading a fleet of ships (multiple units) you need to be aware where they are. Are they still in the narrow and dangerous straits or have some emerged to the open seas? Management of multiple units in these times needs to be highly attuned to where the units are. Blanket policies that imply that either everyone is in the same condition rarely work as different markets enter and emerge from recessions at different speeds.